Webb et al. investigated TILs in a large collection of primary ovarian tumors and confirmed that CD103+ TILs is strongly associated with patient survival in ovary cancer, which may serve as a useful marker for enriching the most beneficial subsets for immunotherapy19. Here, ITGAE is linked to ovarian cancer.